Kennedy’s Empty Advisory Panel Leaves U.S. Flu Shot Coverage in Limbo

Vaccine access in the United States has stalled. The federal advisory board that guides public health recommendations is currently vacant. This gap is creating immediate financial and logistical hurdles for patients and insurers alike.

Health and Human Services Secretary Robert F. Kennedy Jr. restructured vaccination policy earlier this year. He reduced childhood immunization recommendations by one-third. He also replaced the experts on the Advisory Committee on Immunization Practices with selected allies. A federal judge later halted these changes. The ruling found the administration did not follow proper procedures. Kennedy has not nominated new members since. No fresh recommendations have emerged despite new vaccine approvals.

The impact is visible in local healthcare settings. Ron Kroening, 63, sought Moderna’s new mRNA flu vaccine. The Food and Drug Administration approved the shot in August for adults over 50. Clinical trials indicate it provides stronger protection than standard flu vaccines. Kroening had to locate a single pharmacy in his area that stocked the dose. He paid a $40 co-pay. His insurer denied coverage because the vaccine is not on the ACIP list. Kroening, a retired public health employee from Oklahoma, stated that any barrier to vaccination discourages people from getting shots.

Insurance rules typically give companies more than a year to add coverage for new vaccines. An early co-pay is not rare. The current uncertainty differs because no timeline exists for full coverage. Insurers usually have one year from an ACIP recommendation to cover a vaccine by the next plan year. A recommendation in December 2026 would require coverage by January 2028. A recommendation in January 2027 would push coverage to January 2029. Lindsay Wiley, a law professor at UCLA, noted that the legal requirement does not take effect immediately. She described a recommendation next year as the best-case scenario for the new flu shot. She said there is no reason to expect one soon.

Covid vaccines remain the sole exception. Congress amended the Affordable Care Act to require coverage within 15 days of an ACIP recommendation. Other areas face distinct consequences. Some states prohibit pharmacists from administering vaccines without an ACIP recommendation. Decisions made before the committee was disbanded were also halted. This includes a September 2025 recommendation on new RSV shots. Insurers appear to be covering those shots anyway. A voided vote to end the universal hepatitis B birth dose is now influencing potential state laws. Delays have also appeared in Medicare coverage for senior flu shots, despite laws requiring it without a recommendation.

The government has appealed the ruling that disbanded the committee. Experts say nothing prevents Kennedy from following the correct process to appoint new members. Aaron Siri, who served as Kennedy’s lawyer, wrote on Monday that the White House and the Department of Justice are not making a serious attempt to revive the committee. Dorit Reiss, a vaccines expert at UC Law San Francisco, agreed. She said the federal government is choosing not to install a new ACIP.

Reiss suggested an empty committee may suit Kennedy. His appointees did not move as quickly as he wanted to change the schedule. Bypassing ACIP and delaying its reconstitution could allow him to make his own recommendations. She warned that the committee’s future remains shaky even after the court case ends. Trust in its independence has been aggressively undermined. Restoring it may require a statute giving it protection.

Kroening’s insurer belongs to the industry group AHIP. The group vowed to keep covering all shots recommended as of September 2025. Insurers can also choose to cover vaccines before they must. Kroening said he would still pick the new vaccine. He is glad he paid for it. He is unhappy that insurance did not cover the cost. He said, “It's a mess right now, what they're doing with our vaccines.”